G1 Therapeutics Cash from Investing (TTM) Analysis

G1 Therapeutics Inc (GTHX)

3.765 +0.04 (+1.21%) USD | NASDAQ | Apr 30, 16:00

4.00 +0.24 (+6.24%) After-Hours: 18:32

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	2.81M
September 30, 2023	-9.905M
June 30, 2023	-46.77M
March 31, 2023	-47.62M
December 31, 2022	-50.53M
September 30, 2022	-30.17M
June 30, 2022	-0.506M
March 31, 2022	0.00
December 31, 2021	0.00
September 30, 2021	0.00
June 30, 2021	0.152M
March 31, 2021	0.152M
December 31, 2020	0.152M
September 30, 2020	-0.948M
June 30, 2020	-2.324M

Date	Value
March 31, 2020	-2.50M
December 31, 2019	-2.716M
September 30, 2019	-1.727M
June 30, 2019	-0.917M
March 31, 2019	-0.854M
December 31, 2018	-0.709M
September 30, 2018	-0.622M
June 30, 2018	-0.444M
March 31, 2018	-0.352M
December 31, 2017	-0.294M
September 30, 2017	-0.311M
June 30, 2017	-0.199M
March 31, 2017	-0.2067M
December 31, 2016	-0.25M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-50.53M

Minimum

Dec 2022

2.81M

Maximum

Dec 2023

-10.18M

Average

-0.948M

Median

Sep 2020

Cash from Investing (TTM) Benchmarks